✦ LIBER ✦

Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism

✍ Scribed by Arthur L. Burnett; Trinity J. Bivalacqua; Hunter C. Champion; Biljana Musicki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Feasibility of the Use of Phosphodie

✍ Tom F. Lue; Anthony J. Bella 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Is there a role for phosphodiesterase ty

✍ Aversa, A; Francomano, D; Bruzziches, R; Natali, M; Spera, G; Lenzi, A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 303 KB

Phosphodiesterase type 5 inhibitors for

✍ Vickers, M A; Satyanarayana, R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

T08-O-14 Sexual identity, sexual relatio

✍ S. Pierucci; G. Corretti 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Patterns of switching phosphodiesterase

✍ D. Hatzichristou; J. M. Haro; A. Martin-Morales; A. Von Keitz; A. Riley; J. Bert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Does Current Scientific and Clinical Evi

✍ Anastasios D. Asimakopoulos; Roberto Miano; Enrico Finazzi Agrò; Giuseppe Vespas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB